Comparative Study of FISH, PCR and Cytogenetics on 25 Patients Submitted to Bone Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML); Which Tests can we Use in Routine Analysis Post BMT?

References

• Goldman, J. M., Apperley, J. F., Jones, L. M., Marcus, R. E., Goolden, A.W.G., Batchelor, J. R., Hale, G., Waldmann, H., Reid, C. D., Hows, J. M., Gordon-Smith, E., Cadovsky, D. and Galton, D. A. G. (1986). Bone marrow transplantation for patients with chronic myeloid leukemia, New Engl. J. Med., 314, 202–207.
   PubMed Web of Science ®Google Scholar
• Radich, J. P., Gehly, G., Gooley, T., Bryant, E., Clift, R. A., Collins, S., Edmands, S., Kirt, J., Lee, A., Kessler, P., Schoch, G., Buckner, C. D., Sullivan, K. M., Appelbaum, F. R. and Thomas, E. D. (1995). Polymerase chain reaction detection of the BCR—ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 364 patients, Blood, 85, 2632–2638.
   PubMed Web of Science ®Google Scholar
• Palka, G., Di Bartolomeo, P., Iacone, A., Di Girolamo, G., Betti, S., Calabrese, G., Natale, D., Stuppia, L., Rieve, A. K. and Torlontano, G. (1986). Cytogenetics and bone marrow transplantation, Cancer Genet. Cytogenet., 21, 147–157.
   PubMedGoogle Scholar
• Bar, B. M. A. M., Schattenberg, A. and van Dijk, B. A. (1989). Host and donor erythrocyte repopulation patterns after allogeneic bone marrow transplantation analyzed with antibody fluorescent microspheres, Br. J. Haematol., 72, 239–245.
   PubMed Web of Science ®Google Scholar
• Calabrese, G., Di Bartolomeo, P., Stuppia, Guanciali Franchi, P., Parruti, G., Giancarelli, M., Angrilli, F., Geraci, L. and Palka, G. (1989). Cytogenetics in patients with chronic myelogenous leukemia treated with bone marrow transplantation, Cancer Genet. Cytogenet., 41, 49–59.
   PubMedGoogle Scholar
• Lawler, M., Humphries, P. and McCann, S. R. (1991). Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction, Blood, 77, 2504–2514.
   PubMed Web of Science ®Google Scholar
• Okamoto, R., Harano, H., Matsuzaki, M., Motomura, S., Maruta, A., Kodama, F., Mohri, H. and Okubo, T. (1995). Predicting relapse of chronic myelogenous leukemia after bone marrow transplantation by BCR—ABL mRNA and DNA fingerprinting. Am. J. Clin. Pathol., 104, 510–516.
   PubMed Web of Science ®Google Scholar
• Gosálvez, J., Lòpez-Fernández, C., Buno, I., Polo, N., Llmas, P., Fernàndez, M. N., Fernàndez, J. L. and Dièz-Matín, J. L. (1996). Restriction endonuclease in situ digestion (REISD) 145 and fluorescence in situ hybridization (FISH) as complementary methods to analyze chimerism and residual disease after bone marrow transplantation, Cancer Genet. Cytogent., 89, 141–145.
   PubMedGoogle Scholar
• El-Rifai, W., Ruutu, T., Vettenranta, K., Temtamy, Samia and Knuutila, S. (1996). Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia: a metafase-FISH study, Br. J. Haematol., 92, 365–369.
   PubMed Web of Science ®Google Scholar
• Palka, G., Stuppia, L., Di Bartolomeo, P., Morizio, E., Peila, R., Guanciali Franchi, P. and Calabrese, G. (1995). FISH detection of mixed chimerism in 33 patients submitted to bone marrow transplantation, Bone Marrow Transplant., 17, 231–236.
   Web of Science ®Google Scholar
• Gardiner, N., Lawler, M., O Riordan, J., De Arce, M., Humphires, P. and McCann, S. R. (1997). Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukemia, Bone Marrow Trasnplant. 20, 235–241.
   PubMed Web of Science ®Google Scholar
• Lawler, M., McCann, S. R., Conneally, E. and Humphries, P. (1989). Chimersim following allogenic bone marrow transplantation: detection of residual host cells using the polymerase chain reaction, Br. J. Haematol, 68, 205–210.
   Web of Science ®Google Scholar
• Gabert, J., Lafage, M., Maraniniki, D., Thuret, I., Carcassonne, Y. and Mannoni, P. (1989). Detection of residual bcr/ab1 translocation by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation, Lancet, 2, 1125–1128.
   PubMed Web of Science ®Google Scholar
• Morgan, G. J., Janssen, J. W. G., Guo, A. P., Wiedemann, M., Hughes, T., Gow, J., Goldman, J. M. and Bartram, C. R. (1989). Polymerase chain reaction for detection of residual disease, Lancet, 1, 928–929.
   PubMed Web of Science ®Google Scholar
• Stuppia, L., Calabrese, G., Guanciali Franchi, P., Di Bartolomeo, P., Antonucci, A., Peila, R., Torlontano, G. and Palka, G. (1993). Detection of minimal residual disease by polymerase chain reaction in patients with different hematologic diseases treated by bone marrow transplantation, Cancer Genet. Cytogenet., 65, 88–92.
   PubMedGoogle Scholar
• Lin, F., Kirkland, M. A., Van Rhee, F., Chase, A., Coulthard, S., Bungey, J., Goldman, J. M. and Cross, N. C. P. (1996). Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia, Bone Marrow Transplant., 18, 1147–1152.
   PubMed Web of Science ®Google Scholar
• Van Rhee, F., Marks, D. I., Lin, F. et al. (1995). Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia-comparison of blood and bone marrow, Leukemia, 9, 329–335.
   PubMed Web of Science ®Google Scholar
• Poddighe, P. J., Moesker, O., Smeets, D., Awwad, B. H., Ramaekers, F. C. S. and Hopman, A. H. N. (1991). Interphase cytogenetics of hematological cancer: comparision of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes, Cancer Res., 51, 1959–1967.
   PubMed Web of Science ®Google Scholar
• Dewald, G. W., Schad, C. R., Christensen, E. R., Law, M. E., Zinsmeister, A. R., Stalboerger, P. G., Jalal, S. M., Ash, R. C. and Jenkins, R. B. (1993). Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation, Bone Marrow Transplant., 12, 149–152.
   PubMed Web of Science ®Google Scholar
• Zhao, L., Kantarjian, H. M., Van Oort, J., Cork, A., Trujillo, J. M. and Liang, J. C. (1993). Detection of residual proliferating leukemic cells by fluorescence in situ hybridization in CML patients in complete remission after interferon treatment, Leukemia, 7, 168–171.
   PubMed Web of Science ®Google Scholar
• Nagler, A., Slavin, S., Yarkoni, S., Fejgin, M. and Amiel, A. (1994). Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization, Cancer Genet. Cytogenet., 73, 130–133.
   PubMedGoogle Scholar
• Amiel, A., Yarkoni, S., Slavin, S., Or, R., Lorberboum-Galski, H., Fejgin, M. and Nagler, A. (1994). Detection of minimal residual disease state in chronic myelogeneous leukemia patients using fluorescence in situ hybridization, Cancer Genet. Cytogenet., 76, 59–64.
   PubMed Web of Science ®Google Scholar
• Calabrese, G., Stuppia, L., Guanciali Franchi, P., Peila, R., Morizio, E., Liberati, A. M., Spadano, A., Di Lorenzo, R., Ronti, E., Antonucci, A. and Palka, G. (1994). Complex translocations of the Ph negative CML arise from similar mechanisms as evidence by FISH analysis, Cancer Genet. Cytogenet., 78, 153–159.
   PubMed Web of Science ®Google Scholar
• Van der Plas, D., Grosveld, G. and Hagemeijer, A. (1991). Reveiw of clinical cytogenetic and molecular aspects of Ph-negative CML, Cancer Genet. Cytogenet., 52, 143–156.
   PubMed Web of Science ®Google Scholar
• Palka, G., Calabrese, G., Di Girolamo, G., Stuppia, L., Di Bartolomeo, P., Guanciali Franchi, P., Di Virgilio, C., Bianchi, P. G., Angrilli, F., Parrutti, G. and Torlontano, G. (1991). Cytogenetic survey of 31 patients treated with bone marrow transplantation for acute non lymphocytic and acute lymphoblastic leukemias, Cancer Genet. Cytogenet., 15, 223–233.
   Google Scholar
• Socie, G., Lawler, M., Gluckman, E., McCann, S. R. and Brison, O. (1995). Studies on hemopoietic chimaerism following allogeneic bone marrow transplantation in the molecular biology era, Leukemia Res., 19, 497–504.
   PubMed Web of Science ®Google Scholar
• Pignon, J. M., Henni, T., Amselem, S., Viduad, M., Duquesnoy, P., Vernant, J. P., Keutz, M., Cordonnier, C., Rochant, H. and Goosens, M. (1990). Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia, Leukemia, 4, 83–87.
   PubMed Web of Science ®Google Scholar
• Delage, R., Soiffer, R. J., Dear, K. and Ritz, J. (1993). Clinical significance of bcr—abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia, Blood, 78, 2759–2767.
   Web of Science ®Google Scholar
• Wessman, M., Popp, S., Ruutu, T., Volin, L., Cremer, T. and Knuutila, S. (1993). Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization and karyotype analysis, Bone Marrow Transplant., 11, 279–284.
   PubMed Web of Science ®Google Scholar
• Przepiorka, D., Thomas, E. D., Durman, D. M. and Fisher, L. (1991). Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant receipients, Am. J. Clin. Pathol., 95, 201–206.
   PubMed Web of Science ®Google Scholar
• Elmaagacli, A. H., Becks, H. W., Beelen, D. W., Becks, H. W., Mobascher, A., Stockova, J., Trezensky, S. and Opalka, B. (1995). Detection of minimal residual disease and persistence of host type hematopoiesis: a study in 28 patients after bone marrow transplantation for Philadelphia positive chronic myeloid leukemia, Bone Marrow Transplant., 18, 1147–1152.
   Google Scholar
• Zhang, J. G., Lin, F., Chase, A., Goldamn, J. M. and Cross, N. C. P. (1996). Comparation of genomic and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with bone marrow transplantation, Blood, 87, 2588–2593.
   PubMed Web of Science ®Google Scholar
• Roth, M. S., Antin, J. H., Ash, R., Terry, V. H., Gotlieb, M., Silver, S. M. and Ginsburg, D. (1992). Prognostic significance of Philadelphia positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myeloid leukemia, Blood, 79, 276.
   PubMed Web of Science ®Google Scholar
• Miyamura, K., Tahara, T., Tanimoto, M., Morishita, Y., Kawashima, K., Morishima, Y., Saito, H., Tsuzuki, S., Takeyamma, K., Kodera, Y., Matsyma, K., Hirabayashi, N., Yamada, H., Naito, K., Imai, K., Sakamaki, H., Asai, O. and Mizutani, S. (1993). Long persistent bcr—abl positive transcript detected by polymerase chain reaction after bone marrow transplant for chronic myelogenous leukemia without clinical relapse: A study of 64 patients, Blood, 81, 1089.
   PubMed Web of Science ®Google Scholar
• Guerrasio, A., Martinelli, G., Saglio, G., Rosso, C., Zaccaria, A., Rosti, G., Testoni, N., Ambrosetti, A., Izzi, T., Sessarego, M. et al. (1992). Minimal residual disease status in transplanted chronic myelogenous leukemia patients; low incidence of polymerase chain reaction positive cases among 48 long disease free subjects unmanipulated allogeneic bone marrow transplantation, Leukemia, 6, 507.
   PubMed Web of Science ®Google Scholar
• van Rhee, F., Lin, F., O Cullis, J., Spencer, A., Cross, N. C. P., Chase, A., Gericochea, B., Bungey, J., Barrett, J. and Goldman, J. M. (1994). Relapse of chronic myeloid leukemia after allogenic bone marrow transplant: The case for giving donor leukocyte transfussions before the outset of hematologic relapse, Blood, 83, 3377–3383.
   PubMed Web of Science ®Google Scholar
• Cross, N. C. P., Feong, L., Chase, A., Bungey, J., Hughes, T. P. and Goldman, J. M. (1993). Competitive polymerase chain reaction to estimate the number of bcr—abl transcripts in chronic myeloid leukemia patients after bone marrow transplantation, Blood, 82, 1929–1936.
   PubMed Web of Science ®Google Scholar
• Xu, W. M., Piao, X. H., Addy, L., Jamal, N., Minden, M. D. and Messner, H. A. (1994). Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemia, Bone Marrow Transplant., 14, 299–306, 390.
   PubMed Web of Science ®Google Scholar
• Lawler, M. and McCann, S. R., Polymerase chain reaction based methods for assessing chimerism following allogeneic bone marrow transplantation. In: Methods in Molecular medicine, Molecular Diagnosis of cancer. Ed. Cotter F. E., Humana Press Inc., Totowa N. J., pp. 105–120.
   Google Scholar
• Seong, D., Giralt, S., Fischer, H., Hayes, K., Glassman, A., Arlinghaus, R., Xu, J., Kantarjian, H., Siciliano, M. and Champlin, R. (1997). Usefulness of detection of minimal residual disease by hypermetafase fluorescent in situ hybridization after allogeneic BMT for chronic myelogeneous leukemia, Bone Marrow Transplant., 19, 565–570.
   PubMed Web of Science ®Google Scholar
• Pinkel, D., Straume, T. and Gray, V. W. (1986). Cytogenetic analysis using quantitative high-resolution fluorescence hybridization, Proc. Natl. Acad. Sci. USA, 83, 2934–2938.
   PubMed Web of Science ®Google Scholar
• Roy, D. C., Tantravahi, R., Murray, C., Dear, K., Gorgone, B., Anderson, K. C., Freedman, A. S., Nadler, L. M. and Ritz, J. (1990). Natural history of mixed chimerism after bone marrow transplantation with_CD6 depleted allogeneic marrow; a stable equilibrium, Blood, 75, 296–304.
   PubMed Web of Science ®Google Scholar
• Mackinnon, S., Barnett, L., Bourhis, J. H., Black, P., Heller, G. and O'Reilly, R. J. (1992). Myeloid and lymphoid chimerism after T cell depleted bone marrow transplantation: Evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA, Blood, 80, 3235–3241.
   PubMed Web of Science ®Google Scholar
• Roux, E., Abdi, K., Speiser, D., Helg, C., Chapuis, B., Jeannet, M. and Roosnek, E. (1993). Characterisation of mixed chimerism in patients with chronic myeloid leukaemia transplanted with T cell-depleted marrow, involvement of different hemopoietic lineages before and after relapse, Blood, 81, 243–248.
   PubMed Web of Science ®Google Scholar
• Calabrese, G., Sallese, M., Stornaiuolo, A., Stuppia, L., Palka, G. and De Blasi, A. (1994). Chromosome mapping of the human arrestin (SAG) β-arrestin 2 (ARRB2) and β-adrenergic receptor kinase 2 (ADRBK2) genes, Genomics, 23, 286–288.
   PubMed Web of Science ®Google Scholar
• Kolb, H. J., Mittermuller, J., Clemm, C., Holler, E., Ledrerose, G., Brehm, G., Heim, M. and Wilmanns, W. (1990). Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukaemia in marrow transplant patients, Blood, 76, 2462–2465.
   PubMed Web of Science ®Google Scholar
• Gardiner, N., Lawler, M., O Riordan, J. M., Duggan, C., De Arce, M. A. and McCann, S. R. (1998). Monitoring of lineage specific chimaeriosm allow early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukaemia, Bone Marrow Transplant., 21, 711–719.
   PubMed Web of Science ®Google Scholar